High impact of depression in heart failure: Early diagnosis and treatment options

International Journal of Cardiology

Volumn 125, Issue 2, 2008, Pages 220-231

  Norra, Christine ^a,c   Skobel, Eric C ^a,b   Arndt, Marlies ^a   Schauerte, Patrick ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b Center for Cardiac and Pulmonary Rehabilitation   (Germany)

^c MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

Antidepressant treatment; Chronic heart failure; Depression; Diagnosis; Pathogenesis; Risk factors

Indexed keywords

AMFEBUTAMONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CARBAMAZEPINE; CITALOPRAM; CLONIDINE; DOPAMINE UPTAKE INHIBITOR; DULOXETINE; FLUOXETINE; FLUVOXAMINE; HYPERICUM EXTRACT; LAMOTRIGINE; LITHIUM; MIRTAZAPINE; NEUROLEPTIC AGENT; NORADRENALIN UPTAKE INHIBITOR; NORFLUOXETINE; NORTRIPTYLINE; PAROXETINE; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE; VERAPAMIL;

ALCOHOL WITHDRAWAL; ANTICHOLINERGIC EFFECT; ANXIETY DISORDER; ASYSTOLE; ATRIOVENTRICULAR BLOCK; BIPOLAR DISORDER; BLEEDING; BLOOD PRESSURE; BRADYCARDIA; CLINICAL FEATURE; COGNITIVE THERAPY; COMORBIDITY; COPING BEHAVIOR; DELIRIUM; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIGITALIS INTOXICATION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG HALF LIFE; DRUG TOLERABILITY; ECG ABNORMALITY; ELECTROCARDIOGRAM; EUPHORIA; HALLUCINATION; HEART BLOCK; HEART CONDUCTION; HEART DISEASE; HEART EJECTION FRACTION; HEART FAILURE; HEART FIBRILLATION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE CONTRACTILITY; HEART RATE; HEART RATE VARIABILITY; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTENSION; HYPOTENSION; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; ISCHEMIC HEART DISEASE; LEG EDEMA; MAJOR DEPRESSION; MIGRAINE; ORTHOSTATIC HYPOTENSION; PATHOGENESIS; PATHOPHYSIOLOGY; PHYSIOTHERAPY; PQ INTERVAL; PQ PROLONGATION; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; QRS COMPLEX; QT INTERVAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; SOCIAL SUPPORT; ST SEGMENT ELEVATION; SUDDEN DEATH; T WAVE; TACHYCARDIA; TOBACCO DEPENDENCE; TREATMENT CONTRAINDICATION; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; EARLY DIAGNOSIS; HEART FAILURE; HUMANS; PROGNOSIS; RISK FACTORS;

EID: 40949164274     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.05.020     Document Type: Review

References (144)

1. Jiang W., Alexander J., Christopher E., et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 161 (2001) 1849-1856
2. Joynt K.E., Whellan D.J., and O'Connor C.M. Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure. J Card Fail 10 (2004) 258-271
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. DSM-IV-TR 5th edition (2000), American Psychiatric Press, Washington DC
4. Murray C.J., and Lopez A.D. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349 (1997) 1436-1442
5. Koenig H.G. Depression in hospitalized older patients with congestive heart failure. Gen. Hosp. Psych. 20 (1998) 29-42
6. Friedman M.M., and Griffin J.A. Relationship of physical symptoms and physical functioning to depression in patients with heart failure. Heart Lung 30 (2001) 98-104
7. Vaccarino V., Kasl S.V., Abramson J., and Krumholz H.M. Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol 38 (2001) 199-205
8. Freedland K.E., Rich M.W., Skala J.A., Carney R.M., Davila-Roman V.G., and Jaffe A.S. Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom Med 65 (2003) 119-128
9. Havranek E.P., Ware M.G., and Lowes B.D. Prevalence of depression in congestive heart failure. Am J Cardiol 84 (1999) 348-350
10. Skotzko C.E., Krichten C., Zietowski G., Alves L., Freudenberger R., and Robinson S. Depression is common and precludes accurate assessment of functional status in elderly patients with congestive heart failure. J Card Fail 6 (2000) 300-305
11. Murberg T.A., and Bru E. Social relationships and mortality in patients with congestive heart failure. J Psychosom Res 51 (2001) 521-527
12. Rumsfeld J.S., Havranek E., Masoudi F.A., et al. Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure. J Am Coll Cardiol 42 (2003) 1811-1817
13. Gottlieb S.S., Khatta M., Friedmann E., Einbinder L., Katzen S., and Baker B. The influence of age, gender, and race on the prevalence of depression in heart failure patients. J Am Coll Cardiol 43 (2004) 1542-1549
14. Havranek E.P., Spertus J.A., Masoudi F.A., Jones P.G., and Rumsfeld J.S. Predictors of the onset of depressive symptoms in patients with heart failure. J Am Coll Cardiol 44 (2004) 2333-2338
15. O'Connor C.M., and Joynt K.E. Depression: are we ignoring an important comorbidity in heart failure?. J Am Coll Cardiol 43 (2004) 1550-1552
16. Ormel J., Koeter M.W., van den Brink W., and van de Willige G. Recognition, management, and course of anxiety and depression in general practice. Arch Gen Psychiatry 48 (1991) 700-706
17. Musselman D.L., Evans D.L., and Nemeroff C.B. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 55 (1998) 580-592
18. Faris R., Purcell H., Henein M., and Coats A. Clinical depression is common and significantly associated with reduced survival in patients with non-ischaemic heart failure. Eur J Heart 4 (2002) 541-551
19. Freedland K.E., Carney R.M., Rich M.W., et al. Depression in elderly patients with congestive heart failure. J Geriatr Psychiatry 24 (1991) 59-71
20. Murberg T.A., Bru E., Svebak S., Tvetaras R., and Aarsland T. Depressed mood and subjective symptoms as predictors of mortality in patients with congestive heart failure: a two-year follow-up study. Int J Psychiatry Med 29 (1999) 311-326
21. Zuccala G., Cocchi A., and Carbonin P. The impact of depression on self-perceived health status. J Am Geriatr Soc 43 (1995) 198-199
22. Westlake C., Dracup K., Fonarow G., and Hamilton M. Depression in patients with heart failure. J Card Fail 11 (2005) 30-35
23. Turvey C.L., Schultz K., Arndt S., Wallace R.B., and Herzog R. Prevalence and correlates of depressive symptoms in a community sample of people suffering from heart failure. J Am Geriatr Soc 50 (2002) 2003-2008
24. Frasure-Smith N., Lesperance F., Gravel G., et al. Social support, depression, and mortality during the first year after myocardial infarction. Circulation 101 (2000) 1919-1924
25. Luber M.P., Meyers B.S., Williams-Russo P.G., et al. Depression and service utilization in elderly primary care patients. Am J Geriatr Psychiatry 9 (2001) 169-176
26. Majani G., Pierobon A., Giardini A., et al. Relationship between psychological profile and cardiological variables in chronic heart failure. The role of patient subjectivity. Eur Heart J 20 (1999) 1579-1586
27. Sullivan M., Simon G., Spertus J., and Russo J. Depression-related costs in heart failure care. Arch Intern Med 162 (2002) 1860-1866
28. Peacock IV W.F., Young J., Collins S., Diercks D., and Emerman C. Heart failure observation units: optimizing care. Ann Emerg Med 47 (2006) 22-33
29. Abramason J., Berger A., Krumholz H.M., and Vaccarino V. Depression and risk of heart failure among older persons with isolated systolic hypertension. Arch Intern Med 161 (2001) 1725-1730
30. Williams S.A., Kasl S.V., Heiat A., Abramson J.L., Krumholz H.M., and Vaccarino V. Depression and risk of heart failure among the elderly: a prospective community-based study. Psychosom Med 64 (2002) 6-12
31. Jiang W., Hasselbad V., Krishan R.R., and O ́Connor C.M. Patients with CHF and depression have a greater risk of mortality and morbidity than patients without depression. J Am Coll Cardiol 39 (2002) 919-921
32. Clarke S.P., Frasure-Smith N., Lesperance F., and Bourassa M.G. Psychosocial factors as predictors of functional status at 1 year in patients with left ventricular dysfunction. Res Nurs Health 23 (2000) 290-300
33. Krumholz H.M., Butler J., Miller J., Vaccarino V., Williams C.S., and Mendes de Leon C.F. Prognostic importance of emotional support for elderly patients hospitalized with heart failure. Circulation 97 (1998) 958-964
34. Pepper G.S., and Lee R.W. Sympathetic activation in heart failure and its treatment with beta-blockade. Arch Intern Med 159 (1999) 225-234
35. Maas J.W., Katz M.M., Koslow S.H., et al. Adrenomedullary function in depressed patients. J Psychiatr Res 28 (1994) 357-367
36. Ehlert U., Gaab J., and Heinrichs M. Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: the role of the hypothalamus-pituitary-adrenal axis. Biol Psychol 57 (2001) 141-152
37. Liu Y., and Nakamura S. Stress-induced plasticity of monoamine axons. Front Biosci 11 (2006) 1794-1801
38. Carney R.M., Freedland K.E., Veith R.C., et al. Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease. Biol Psychiatry 45 (1999) 458-463
39. Jiang W., Hathaway W.R., McNulty S., et al. Ability of heart rate variability to predict prognosis in patients with advanced congestive heart failure. Am J Cardiol 80 (1997) 808-811
40. Gorman J.M., and Sloan R.P. Heart rate variability in depressive and anxiety disorders. Am Heart J 140 Suppl 4 (2000) 77-83
41. Yeragani V.K., Pohl R., Jampala V.C., Balon R., Ramesh C., and Srinivasan K. Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder. Depress Anxiety 11 (2000) 126-130
42. Naujokat E., Arndt M., and Norra C. A new data acquisition system for ambulatory long-term monitoring of HRV and activity: a pilot study (EU Project MYHeart). Somnologie 10 S1 (2006) 32 [Abstract]
43. Ramage A.G. Central cardiovascular regulation and 5-hydroxytryptamine receptors. Brain Res Bull 56 (2001) 425-439
44. Stein P.K., Carney R.M., Freedland K.E., et al. Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease. J Psychosom Res 48 (2000) 493-500
45. Carney R.M., Blumenthal J.A., Stein P.K., et al. Depression, heart rate variability, and acute myocardial infarction. Circulation 104 (2001) 2024-2028
46. Drago S., Bergerone S., Anselmino M., et al. Depression in patients with acute myocardial infarction: Influence on autonomic nervous system and prognostic role. Results of a five-year follow-up study. Int J Cardiol 115 (2007) 46-51
47. Khaykin Y., Dorian P., Baker B., et al. Autonomic correlates of antidepressant treatment using heart-rate variability analysis. Can J Psychiatry 43 (1998) 183-186
48. Roose S.P., Glassman A.H., Giardina E.G., Walsh B.T., Woodring S., and Bigger J.T. Tricyclic antidepressants in depressed patients with cardiac conduction disease. Arch Gen Psychiatry 44 (1987) 273-275
49. Glassman A.H., O'Connor C.M., Califf R.M., et al. Sertraline Antidepressant Heart Attack Randomized Trial (SADHEART) Group. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288 (2002) 701-709
50. Levine B., Kalman J., Mayer L., Fillit H.M., and Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323 (1990) 236-241
51. Blum A., and Miller H. Pathophysiological role of cytokines in congestive heart failure. Annu Rev Med 52 (2001) 15-27
52. Roose S.P. Treatment of depression in patients with heart disease. Biol Psychiatry 54 (2003) 262-268
53. Appels A., Bar F.W., Bar J., Bruggeman C., and de Baets M. Inflammation, depressive symptomatology, and coronary artery disease. Psychosom Med 62 (2000) 601-605
54. Maes M., Meltzer H.Y., Bosmans E., et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 34 (1995) 301-309
55. Seidel A., Arolt V., Hunstiger M., Rink L., Behnisch A., and Kirchner H. Cytokine production and serum proteins in depression. Scand J Immunol 41 (1995) 534-538
56. Kop W.J., Gottdiener J.S., Tangen C.M., et al. Inflammation and coagulation factors in persons > 65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol 89 (2002) 419-424
57. Al-Khadra A.S., Salem D.N., Rand W.M., Udelson J.E., Smith J.J., and Konstam M.A. Warfarin anticoagulation and survival: a cohort analysis from the studies of left ventricular dysfunction. J Am Coll Cardiol 31 (1998) 749-753
58. Gibbs C.R., Blann A.D., Watson R.D., and Lip G.Y. Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy. Circulation 103 (2001) 1746-1751
59. Von Kanel R., Mills P.J., Fainman C., and Dimsdale J.E. Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease?. Psychosom Med 63 (2001) 531-544
60. Folsom A.R., Qamhieh H.T., Flack J.M., et al. Plasma fibrinogen: levels and correlates in young adults. The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol 138 (1993) 1023-1036
61. Lederbogen F., Gilles M., Maras A., et al. Increased platelet aggregability in major depression?. Psychiatry Res 102 (2001) 255-261
62. Sheline Y.I., Bardgett M.E., Jackson J.L., Newcomer J.W., and Csernansky J.G. Platelet serotonin markers and depressive symptomatology. Biol Psychiatry 37 (1995) 442-447
63. Whyte E.M., Pollock B.G., Wagner W.R., et al. Influence of serotonin-transporter-linked promoter region polymorphism on platelet activation in geriatric depression. Am J Psychiatry 158 (2001) 2074-2076
64. Sharafkhaneh A., Giray N., Richardson P., Young T., and Hirshkowitz M. Association of psychiatric disorders and sleep apnea in a large cohort. Sleep 28 (2005) 1405-1411
65. Skobel E., Norra C., Kaminski R., et al. Sleep, mood and health related quality of life in patients with chronic heart failure is impaired by nocturnal central sleep apnea. Eur J Heart Fail 7 (2005) 505-511
66. Lanfranchi P.A., Braghiroli A., Bosimini E., Mazzuero G., Colombo R., and Donner C.F. Prognostic value of nocturnal Cheyne-Stokes respiration in congestive heart failure. Circulation 99 (1999) 1435-1440
67. Lanfranchi P.A., Somers V.K., Braghiroli A., Corra U., Eleuteri E., and Giannuzzi P. Central sleep apnea in left ventricular dysfunction: prevalence and implications for arrhythmic risk. Circulation 107 (2003) 727-732
68. Bradley T.D., and Floras J. Sleep apneas and heart failure: part II: Central sleep apnea. Circulation 107 (2003) 1822-1826
69. Javaheri S., Parker T.J., Liming J.D., et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 97 (1998) 2154-2159
70. Sinha A.M., Skobel E., Breithardt O., Norra C., Breuer C., and Markus K. Brain natriuretic peptide release correlates with sleep related breathing disorders in patients with chronic heart failure. Eur Heart J 25 (2004) 572 [Abstract]
71. Rao A., Georgiadou P., Francis D.P., et al. Sleep-disordered breathing in a general heart failure population: relationships to neurohumoral activation and subjective symptoms. J Sleep Res 15 (2006) 81-88
72. DiMatteo M.R., Lepper H.S., and Croghan T.W. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160 (2000) 2101-2107
73. van der Wal M.H., Jaarsma T., and van Veldhuisen D.J. Non-compliance in patients with heart failure; how can we manage it?. Eur J Heart Fail 7 (2005) 5-17
74. Li H.K., Ma W.Z., and Liao J. Left ventricular relaxation and compliance in normal subjects. Zhonghua Xin Xue Guan Bing Za Zhi 16 (1988) 92-94
75. Hawthorne M.H., and Hilton M.E. Functional status, mood disturbance and quality of life in patients with heart failure. Prog Cardiovasc Nurs 9 (1994) 22-32
76. Monane M., Bohn R.L., Gurwitz J.H., Glynn R.J., and Avorn J. Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med 154 (1994) 433-437
77. Michalsen A., Konig G., and Thimme W. Preventable causative factors leading to hospital admission with decompensated heart failure. Heart 80 (1998) 437-441
78. Glazer K.M., Emery C.F., Frid D.J., and Banyasz R.E. Psychological predictors of adherence and outcomes among patients in cardiac rehabilitation. J Cardiopulm Rehabil 22 (2002) 40-46
79. Carney R.M., Freedland K.E., Eisen S.A., Rich M.W., and Jaffe A.S. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol 14 (1995) 88-90
80. Keller S. Neuropsychiatric effects of cardiovascular drug therapy. Cardiol Rev 11 (2003) 73-93
81. Benkert O., and Hippius H. Kompendium der Psychiatrischen Pharmakotherapie. 5th edition (2005), Springer, Heidelberg, Berlin
82. Ko D.T., Hebert P.R., Coffey C.S., Sedrakyan A., Curtis J.P., and Krumholz H.M. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 288 (2002) 351-357
83. Norra C. Depressive syndromes in hypertension. In: Hegerl U., and Hoff P. (Eds). Treatment of depression under complicated conditions. Comorbidity - Polypharmacy - Geriatric patients (2003), UNI-MED, Bremen 44-64
84. Carney R.M., Freedland K.E., Sheline Y.I., and Weiss E.S. Depression and coronary heart disease: a review for cardiologists. Clin Cardiol 20 (1997) 196-200
85. World Health Organization. Tenth Revision of the International Classification of Diseases, Chapter (V): mental and behavioural disorders (including disorders of psychological development). Clinical Descriptions and Diagnostic Guidelines. WHO, 1991.
86. The Task Force of the Working Group on Heart Failure of the European Society of Cardiology Guideline for the diagnosis and treatment of chronic heart failure. Eur Heart J 17 (2001) 1527-1560
87. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 4 (1961) 561-571
88. Burnam M.A., Wells K.B., Leake B., and Landsverk J. Development of a brief screening instrument for detecting depressive disorders. Med Care 26 (1988) 775-789
89. Whooley M.A., Avins A.L., Miranda J., and Browner W.S. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med 12 (1997) 439-445
90. Whooley M.A., and Simon G.E. Managing depression in medical outpatients. N Engl J Med 343 (2000) 1942-1950
91. In: Bech P. (Ed). Rating scales for psychopathology, health status and quality of life (1993), Springer, Heidelberg 325-340
92. Zung W.W. A self-rating depression scale. Arch Gen Psychiatry 12 (1965) 63-70
93. Yesavage JA, Brink TL, Rose TL et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982-83; 17:37-49.
94. Radloff L.S. The CES-D scale: a self report depression scale for research in the general population. Appl Psychol Meas 1 (1977) 385-401
95. Goldberg D.P., and Hillier V.F. A scaled version of the General Health Questionnaire. Psychol Med 9 (1979) 139-145
96. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-62
97. Asberg M., Montgomery S.A., Perris C., Schalling D., and Sedvall G. A comprehensive psychopathological rating scale. Acta Psychiatr Scand Suppl 271 (1978) 5-27
98. Bauer M., Whybrow P.C., Angst J., Versiani M., and Moller H.J. World Federation of Societies Biological Psychiatry Task Force on Treatment Guidelines for Unipolar Depressive Disorders. (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder. World J Biol Psychiatry 3 (2002) 5-43
99. Fraticelli A., Gesuita R., Vespa A., and Paciaroni E. Congestive heart failure in the elderly requiring hospital admission. Arch Gerontol Geriatr 23 (1996) 225-238
100. Conti C.R. The modern treatment of heart failure: how many drugs are enough?. Clin Cardiol 23 (2000) 139-140
101. Glassman A.H., Roose S.P., and Bigger Jr. J.T. The safety of TCAs in cardiac patients - risk/benefit reconsidered. JAMA 269 (1993) 2673-2675
102. Coupland N., Wilson S., and Nutt D. Antidepressant drugs and the cardiovascular system: a comparison of tricyclics and selective serotonin reuptake inhibitors and their relevance for the treatment of psychiatric patients with cardiovascular problems. J Psychopharmacol 11 (1997) 83-92
103. Glassman A.H. Cardiovascular effects of antidepressant drugs: updated. Int Clin Psychopharmacol 13 (1998) S25-S30
104. In: Arolt V., and Diefenbacher A. (Eds). Psychiatrie in der klinischen Medizin. Konsiliarpsychiatrie, -psychosomatik und -psychotherapie (2004), Steinkoff Verlag, Darmstadt
105. Glassman A.H., Johnson L.L., Giardina E.G., et al. The use of imipramine in depressed patients with congestive heart failure. JAMA 250 (1983) 1997-2001
106. Nelson J.C., Kennedy J.S., Pollock B.G., et al. Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease. Am J Psychiatry 156 (1999) 1024-1028
107. Roose S.P., Glassmann A.H., Attia E., Woodring S., Giardina E.G., and Bigger Jr. J.T. Cardiovascular effects of fluoxetine in depressed patients with heart disease. Am J Psychiatry 155 (1998) 660-665
108. Shapiro P.A., Lesperance F., Frasure-Smith N., et al. An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Sertraline Anti-Depressant Heart Attack Trial. Am Heart J 137 (1999) 1100-1106
109. Erfurth A., Loew M., Dobmeier P., and Wendler G. ECG-induced changes with paroxetin. Three case reports. Nervenarzt 69 (1998) 629-631
110. Hesslinger B., Harter M., Barth J., et al. Comorbidity of depressive disorders and cardiovascular diseases. Implications for diagnosis, pharmaco- and psychotherapy. Nervenarzt 73 (2002) 205-217
111. Goddnick P.J., and Goldstein B.J. Selective serotonin reuptake inhibitors in affective disorders - basic pharmacology. J Psychopharmacol 12 Suppl B (1998) 5-20
112. Serebruany V.L. Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something?. Am J Med 119 (2006) 113-116
113. Musselman D.L., Marzec U.M., Manatunga A., et al. Platelet reactivity in depressed patients treated with paroxetine: preliminary findings. Arch Gen Psychiatry 57 (2000) 875-882
114. Pollock B.G., Laghrissi-Thode F., and Wagner W.R. Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. J Clin Psychopharmacol 20 (2000) 137-140
115. Thase M.E. Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients. J Clin Psychiatry 59 (1998) 502-508
116. Thase M.E., Tran P.V., Wiltse C., Pangallo B.A., Mallinckrodt C., and Detke M.J. Cardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine. J Clin Psychopharmacol 25 (2005) 132-140
117. Roose S.P., Dalack G.W., Glassman A.H., Woodring S., Walsh B.T., and Giardina E.G.V. Cardiovascular effects of bupropion in depressed patients with heart disease. Am J Psychiatry 148 (1991) 512-516
118. Boesen F., Andersen E.B., Jensen E.K., and Ladefoged S.D. Cardiac conduction disturbances during carbamazepine therapy. Acta Neurol Scand 68 (1983) 49-52
119. Lane D., Chong A.Y., and Lip G.Y.H. Psychological interventions for depression in heart failure (Cochrane Review). The cochrane library vol. 4 (2005), John Wiley & Sons, Chichester 1-12
120. Luskin F., Reitz M., Newell K., Quinn T.G., and Haskell W. A controlled pilot study of stress management treating of elderly patients with congestive heart failure. Prev Cardiol 5 (2002) 168-172
121. McCraty R. Effects of an emotional restructuring program on psychological functioning and functional capacity in patients with congestive heart failure. Int J Psychophysiol 5 (2002) 168-172
122. Kostis J.B., Rosen R.C., Cosgrove N.M., Shindler D.M., and Wilson A.C. Nonpharmacologic therapy improves functional and emotional status in congestive heart failure. Chest 106 (1994) 996-1001
123. Carney R.M., Freedland K.E., Stein P.K., Skala J.A., Hoffman P., and Jaffe A.S. Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease. Psychosom Med 62 (2000) 639-647
124. Berkman L.F., Blumenthal J., Burg M., et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 289 (2003) 3106-3116
125. Holahan C.J., Moos R.H., Holahan C.K., and Brennan P.L. Social context, coping strategies, and depressive symptoms: an expanded model with cardiac patients. J Pers Soc Psychol 72 (1997) 918-928
126. Konstam V., Hurley L., Hijjazi K., Perry K., and Konstam M.A. Positive affect: a neglected group treatment outcome in assessing efficacy of psychosocial group interventions in individuals with heart failure. Group 23 (1999) 37-46
127. Murberg T.A., Bru E., Aarsland T., and Svebak S. Social support, social disability and their role as predictors of depression among patients with congestive heart failure. Scand J Soc Med 26 (1998) 87-95
128. Vavouranakis I., Lambrogiannakis E., Markakis G., et al. Effect of home-based intervention on hospital readmission and quality of life in middle-aged patients with severe congestive heart failure: a 12-month follow-up study. Eur J Cardiovasc Nurs 2 (2003) 105-111
129. Stewart S., and Horowitz J.D. Specialist nurse management programmes: economic benefits in the management of heart failure. Pharmacoeconomics 21 (2003) 225-240
130. Martensson J., Stromberg A., Dahlstrom U., Karlsson J.E., and Fridlund B. Patients with heart failure in primary health care: effects of a nurse-led intervention on health-related quality of life and depression. Eur J Heart Fail 7 (2005) 393-403
131. Coats J.A., Adamopoulos S., Meyer T.E., Conway J., and Sleight P. Effects of physical training in chronic heart failure. Lancet 335 (1990) 63-66
132. Koukouvou G., Kouidi E., Iacovides A., Konstantinidou E., Kaprinis G., and Deligiannis A. Quality of life, psychological and physiological changes following exercise training in patients with chronic heart failure. J Rehabil Med 36 (2004) 36-41
133. Wielenga R.P., Huisveld I.A., Bol E., Dunselman P.H., Erdman R.A., and Baselier M.R. Safety and effects of physical training in chronic heart failure. Results of the Chronic Heart Failure and Graded Exercise study (CHANGE). Eur Heart J 20 (1999) 872-879
134. Piepoli M.F., Davos C., Franics D.P., and Coats A.J. ExTraMATCH Collaboration. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ 328 (2004) 189
135. Conraads V.M., Beckers P., Vaes J., et al. Combined endurance/resistance training reduces NT-proBNP levels in patients with chronic heart failure. Eur Heart J 25 (2004) 1797-1805
136. Passino C., Severino S., Poletti R., et al. Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure. J Am Coll Cardiol 47 (2006) 1835-1839
137. Levinger I., Bronks R., Cody D.V., Linton I., and Davie A. Resistance training for chronic heart failure patients on beta blocker medications. Int J Cardiol 102 (2005) 493-499
138. Rechlin T., Weis M., Schneider K., Zimmermann U., and Kaschka W.P. Does bright-light therapy influence autonomic heart-rate parameters?. J Affect Disord 34 (1995) 131-137
139. Linde C., Leclercq C., Rex S., et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in Cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 40 (2002) 111-118
140. Linde C., Braunschweig F., Gadler F., Bailleul C., and Daubert J.C. Long-term improvements in quality of life by biventricular pacing in patients with congestive heart failure: results from the Multisite Stimulation in Cardiomyopathy study (MUSTIC). Am J Cardiol 91 (2003) 1090-1095
141. Sinha A.-M., Skobel E.C., Breithardt O.-A., et al. Cardiac resynchronization therapy improves central sleep apnea and Cheyne-Stokes respiration in patients with chronic heart failure. J Am Coll Cardiol 44 (2004) 68-71
142. Skobel E., Sinha A., Norra C., et al. Effect of cardiac resynchronisation therapy on health related quality of life, sleep quality, and mood in patients with chronic heart failure. Sleep Breath 9 (2005) 159-166
143. Guck T.P., Elsasser G.N., Kavan M.G., and Barone E.J. Depression and congestive heart failure. Congest Heart Fail 9 (2003) 163-169
144. Rich M.W., Gray D.B., Beckham V., Wittenberg C., and Luther P. Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure. Am J Med 101 (1996) 270-276